Oral phosphate binders in patients with kidney failure

N Engl J Med. 2010 Apr 8;362(14):1312-24. doi: 10.1056/NEJMra0912522.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Calcium Compounds / adverse effects
  • Calcium Compounds / therapeutic use*
  • Chelating Agents / adverse effects
  • Chelating Agents / therapeutic use*
  • Humans
  • Hyperphosphatemia / diet therapy
  • Hyperphosphatemia / drug therapy*
  • Hyperphosphatemia / metabolism
  • Kidney Failure, Chronic / drug therapy*
  • Kidney Failure, Chronic / metabolism
  • Lanthanum / adverse effects
  • Lanthanum / therapeutic use
  • Phosphates / metabolism*
  • Polyamines / adverse effects
  • Polyamines / therapeutic use
  • Sevelamer

Substances

  • Calcium Compounds
  • Chelating Agents
  • Phosphates
  • Polyamines
  • lanthanum carbonate
  • Lanthanum
  • Sevelamer